as on November 7, 2025 at 1:45 pm IST
Day's Low
0.88%
Downside
52 Week's Low
52 Week's High
10.78%
Downside
67.54%
Upside
as on November 7, 2025 at 1:45 pm IST
Market Cap
₹12.35 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
-0.22
P/B Ratio
-9.45
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
-7700
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Parmax Pharma Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 12.35 | -3.48% | 0.00 | -3 | 28 | |
| NA | 108.02 | -8.42% | 0.00 | 10 | 40 | |
| NA | 41.32 | 10.88% | 0.69 | 2 | 71 | |
| NA | 440.80 | -10.47% | 0.67 | -3 | 133 | |
| NA | 1,445.66 | 255.65% | 0.00 | 55 | 268 |
Search interest for Parmax Pharma Ltd Stock has increased by 106% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:106% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Parmax Pharma Ltd.
Parmax Pharma Ltd’s net profit fell -7700% since last year same period to ₹0.76Cr in the Q1 2025-2026. On a quarterly growth basis, Parmax Pharma Ltd has generated 48.99% jump in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 30.80% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 111.3% return, outperforming this stock by 119.6%
Retail Holding Unchanged
![]()
Retail Investor holdings remained unchanged at 69.20% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Divis Laboratories Ltd has given 15.5% return, outperforming this stock by 45.3%
Price Dip
![]()
In the last 6 months, Parmax Pharma stock has moved down by -29.5%
| Organisation | Parmax Pharma Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Parmax Pharma Ltd share price today stands at ₹32.84 as on . Parmax Pharma Ltd share today touched a day high of ₹32.84 and a low of ₹32.55.
Parmax Pharma Ltd touched a 52 week high of ₹55.02 and a 52 week low of ₹29.3. Parmax Pharma Ltd share price today i.e. is trending at ₹32.84, which is -40.31% down from its 52 week high and 12.08% up from its 52 week low.
Parmax Pharma Ltd market capitalisation is ₹12.35 Cr as on .
To buy Parmax Pharma Ltd shares, you need to follow these steps:
Parmax Pharma Ltd trading volume is 306.00 as on . This means that 306.00 shares of Parmax Pharma Ltd were bought and sold on the stock market during today's trading session.